Torin2 Exploits Replication and Checkpoint Vulnerabilities to Cause Death of PI3K-Activated Triple-Negative Breast Cancer Cells-Reference-Cited by-同舟云学术

Torin2 Exploits Replication and Checkpoint Vulnerabilities to Cause Death of PI3K-Activated Triple-Negative Breast Cancer Cells

Published:2020-01 Issue:1 Volume:10 Page:66-81.e11
ISSN:2405-4712
Container-title:Cell Systems
language:en
Short-container-title:Cell Systems

Author:

Chopra Sameer S.,Jenney Anne,Palmer Adam,Niepel Mario,Chung Mirra,Mills Caitlin,Sivakumaren Sindhu Carmen,Liu Qingsong,Chen Jia-Yun,Yapp Clarence,Asara John M.,Gray Nathanael S.,Sorger Peter K.

Funder

NIH

DFCI Leadership Council

Conquer Cancer Foundation

Novartis

Merck

Publisher

Elsevier BV

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Reference39 articles.

1. Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer;André;N. Engl. J. Med.,2019

2. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1;Ben-Sahra;Science,2013

3. mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle;Ben-Sahra;Science,2016

4. Rapid functional dissection of genetic networks via tissue-specific transduction and RNAi in mouse embryos;Beronja;Nat. Med.,2010

5. Distinct but concerted roles of ATR, DNA-PK, and Chk1 in countering replication stress during S phase;Buisson;Mol. Cell,2015

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancement in developing small molecular inhibitors targeting key kinase pathways against triple-negative breast cancer;Bioorganic & Medicinal Chemistry;2024-10

2. Integrative modeling uncovers p21-driven drug resistance and prioritizes therapies for PIK3CA-mutant breast cancer;npj Precision Oncology;2024-01-26

3. A drug‐resistant mutation in plant target of rapamycin validates the specificity of ATP‐competitive TOR inhibitors in vivo;The Plant Journal;2023-11-27

4. Development and validation of hierarchical signature for precision individualized therapy based on the landscape associated with necroptosis in clear cell renal cell carcinoma;2023-10-23

5. Paired evaluation of machine-learning models characterizes effects of confounders and outliers;Patterns;2023-08